- Home
- MG vs PRQR Comparison
MG vs PRQR Comparison
Compare MG & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MG
- PRQR
- Stock Information
- Founded
- MG 1978
- PRQR 2012
- Country
- MG United States
- PRQR Netherlands
- Employees
- MG N/A
- PRQR N/A
- Industry
- MG Military/Government/Technical
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- MG Consumer Discretionary
- PRQR Health Care
- Exchange
- MG Nasdaq
- PRQR Nasdaq
- Market Cap
- MG N/A
- PRQR 309.5M
- IPO Year
- MG 2009
- PRQR 2014
- Fundamental
- Price
- MG $7.79
- PRQR $1.55
- Analyst Decision
- MG
- PRQR Strong Buy
- Analyst Count
- MG 0
- PRQR 6
- Target Price
- MG N/A
- PRQR $9.00
- AVG Volume (30 Days)
- MG 116.6K
- PRQR 678.2K
- Earning Date
- MG 05-07-2025
- PRQR 05-08-2025
- Dividend Yield
- MG N/A
- PRQR N/A
- EPS Growth
- MG N/A
- PRQR N/A
- EPS
- MG 0.47
- PRQR N/A
- Revenue
- MG $706,813,000.00
- PRQR $21,212,711.00
- Revenue This Year
- MG $5.76
- PRQR $6.44
- Revenue Next Year
- MG $2.88
- PRQR N/A
- P/E Ratio
- MG $16.52
- PRQR N/A
- Revenue Growth
- MG N/A
- PRQR 85.91
- 52 Week Low
- MG $7.06
- PRQR $1.07
- 52 Week High
- MG $12.44
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- MG 27.60
- PRQR 50.51
- Support Level
- MG $8.87
- PRQR $1.50
- Resistance Level
- MG $9.70
- PRQR $2.02
- Average True Range (ATR)
- MG 0.40
- PRQR 0.17
- MACD
- MG -0.04
- PRQR 0.03
- Stochastic Oscillator
- MG 27.65
- PRQR 48.04
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.